CDK13通过METTL16介导的m6ACLY mRNA的修改驱动清晰细胞癌
Jinsuo Chen1, Huan Liu2, Yong Zhang3
1Clinical Medical College, Hebei University, Department of Urology, Affiliated Hospital of Hebei University, Baoding, China.
循环素依赖性酶13 (CDK13) 通过调节RNA修饰来驱动清细胞细胞癌 (ccRCC) 的脂质代谢. 准CDK13-METTL16-ACLY通路为ccRCC精密疗法提供了一个新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 循环素依赖性激酶13 (CDK13) 与癌症代谢有关.
- 它在清细胞细胞癌 (ccRCC) 脂质代谢中的特定作用尚不清楚.
研究的目的:
- 为了研究CDK13在ccRCC脂质代谢中的功能.
- 阐明CDK13介导的脂质失调背后的分子机制.
- 评估在ccRCC中准CDK13通路的治疗潜力.
主要方法:
- 对ccRCC患者组织中CDK13表达的分析.
- 研究CDK13在新型脂质生成和RNA修饰中的作用.
- 使用生物化学分析识别下游目标和相互作用蛋白.
- 在体外和体内实验中使用基因和药理抑制CDK13通路的实验.
主要成果:
- 过度表达CDK13与晚期ccRCC阶段,预后不佳和脂质积累增加有关.
- CDK13通过依赖酸化的RNAN6 - 甲基氨酸 (m6A) 修饰轴促进新生脂质生成.
- CDK13酸化METTL16,增强m6ACLYmRNA的修饰,导致稳定和增加乙-CoA的生产.
- 破坏CDK13-METTL16-ACLY轴抑制ccRCC瘤生长,脂质沉积和转移.
- 用1NM-PP1准CDK13可以提高METTL16消耗的有效性.
结论:
- CDK13是ccRCC中脂质代谢的关键调节者,通过表皮转录机制.
- CDK13-METTL16-ACLY通路代表了ccRCC的一个新的治疗点.
- 针对这一轴,有望开发有效的针对ccRCC的精密疗法.
更多相关视频
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
相关概念视频
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Spreading of Chromatin Modifications
Writers
The writer...
